Zusammenfassung
Als organische Nitrate bezeichnet man Ester der Salpetersäure mit mehrwertigen Alkoholen. Therapeutische Bedeutung haben in erster Linie die Salpetersäureester des Glycerins (Glyceroltrinitrat), des Isosorbits (Isosorbitdinitrat und Isosorbit-5-mononitrat) und bedingt auch des Pentaerythrits (Pentaerythrittetranitrat) erlangt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abrams, J.: The brief saga of transdermal nitroglycerin doses: Paradise lost? Amer. J. Cardiol. 54, 220 (1984).
Abrams, J.: Tolerance to organic nitrates. Circulation 74, 1181 (1986).
Abshagen, U.: Organic nitrates. In: Handbook of experimental Pharmacology, Vol.76: Clinical pharmacology of antianginal drugs (U. Abshagen, Hrsg.), S. 287. Berlin-Heidelberg- New York-Tokyo: Springer 1985.
Abshagen, U., Betzien, G., Endele, R., Kaufmann, B.: Pharmacokinetics of intravenous and oral isosorbide-5-mononi- trate. Europ. J. clin. Pharmacol. 20, 269 (1981).
Abshagen, U., Betzien, G., Enderle, R., Kaufmann, B., Neu- Gebauer, G.: Pharmacokinetics and metabolism of isosorbidedinitrate after intravenous and oral administration. Europ. J. clin. Pharmacol. 27, 637 (1985).
Akpan, W., Endele, R., Neugebauer, G., Steudel, H.: Pharmacokinetics of IS-5-MN after oral and intravenous administration in patients with hepatic failure. In: Mononitrates (J.N.Cohn, R.Rittinghausen, Hrsg.), S. 86. Berlin-Heidelberg-New York-Tokyo: Springer 1985.
Armstrong, P.W., Armstrong, J. A., Marks, G.S.: Pharmacokinetic hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. Circulation 62, 160 (1980 a).
Armstrong, J. A., Slaughter, S.E., Marks, G.S., Armstrong, P.W.: Rapid disappearance of nitroglycerin following incubation with human blood. Canad. J. Physiol. Pharmacol. 58, 459 (1980 d).
Armstrong, P.W., Moffat, J. A., Marks, G.S.: Arterialvenous nitroglycerin gradient during intravenous infusion in man. Circulation 66, 1273 (1982).
Arsura, E., Guadagnino, V., Lichtstein, E., Bolton, S., Sanders, M., Hollander, G., Greengart, A.: Methemoglobin levels produced by commonly used nitrates. Circulation 66, 11–309 (1982).
Axelsson, K.L., Wikberg, J.E.S., Andersson, R.G.G.: Relationship between nitroglycerin, cyclic GMP and relaxation of vascular smooth muscle. Life Sci. 24, 1779 (1979).
Bartsch, W., Sponer, G., Strein, K., Müller-Beckmann, B., Gessel, B.: Lack of evidence for the role of prostaglandins in the vasodilating effect of organic nitrates. IRCS med. Sci. 11, 67 (1983).
Bassenge, E., Stuart, D. J.: Effects of nitrates in various vascular sections and regions. Z. Kardiol. 75 (Suppl.3), 1 (1986).
Becker, L., Bulkley, B.H., Flaherty, J.: Reduction of late complex ventricular arrhythmias by nitroglycerin in patients with acute myocardial infarction: results of a prospective randomized trial. Circulation 57/58 (Suppl. 2 ), 11–61 (1978).
Blasini, R., Brügmann, U., Mannes, A., Froer, K.L., Hall, D., Rudolph, W.: Wirksamkeit von Isosorbiddinitrat in retardierter Form bei Langzeitbehandlung. Herz 5, 298 (1980).
Blasini, R., Reiniger, G., Brügmann, U., Rudolph, W.: Vermeidung einer Toleranzentwicklung unter Isosorbiddinitrat durch Intervalltherapie. Herz 9, 166 (1984).
Blasini, R., Brügmann, U., Reiniger, G., Rudolph, W.: Langzeittherapie der Belastungs-Angina pectoris durch einmal tägliche Verabreichung von 120 mg Isosorbitddinitrat in retardierter Form: Vergleich von Monotherapie und Kombinationstherapie mit Atenolol und Nifedipin. Herz 10, 163 (1985).
Blasini, R., Reiniger, G., Rudolph, W.: Vermeidung einer Toleranzentwicklung bei Langzeittherapie mit Nitraten durch korrekte Dosierung. Z. Kardiol. 75 (Suppl.3), 42 (1986).
Boertz, A., Bonn, R.: Nitrate therapy without loss of action by correct dosage. Z. Kardiol. 75 (Suppl. 3 ), 57 (1986).
Bogaert, M.G., De Schaepdryver, A.F.: Tolerance towards glycerol trinitrate (trinitrin) in dogs. Arch int. Pharmacodyn. Ther. 171, 221 (1968).
Bogaert, M.G., Rosseel, M.T., Teirlynck, O.: Fate of isosorbide mononitrates in man. In: Nitrates, Vol.III Cardiovascular effects (P. R. Lichtlen, H.J. Engel, Aschrey, H.J.C. Swan, Hrsg.), S. 23. Berlin-Heidelberg-New York: Springer 1981a.
Bogaert, M.G., Rosseel, M.T., Boelaert, J., Daneels, R.: Fate of isosorbide dinitrate and mononitrates in patients with renal failure. Europ. J. clin. Pharmacol. 21, 73 (1981b).
Bogaert, M.G.: Clinical pharmacokinetics of organic nitrates. Clin. Pharmacokin. 8, 410 (1983).
Brodsky, S.J., Halperin, J.L., Klein, M.D., Ryan, T.J.: Intravenous nitroglycerin infusion in unstable angina. Clin. Res. 28, 608 (1980).
Bussmann, W.D., Haler, M.: Hinweis auf eine Abnahme der Früh- und Spätmortalität beim frischen Herzinfarkt unter Nitroglycerintherapie. Klin. Wochenschr. 61, 417 (1983).
Bussmann, W.D., Schöfen, H., Kaltenbach, M.: Effects of intravenous nitroglycerin on hemodynamics and ischemic injury in patients with acute myocardial infarction. Europ. J. Cardiol. 8, 61 (1978).
Carmichel, P., Lieben, P.J.: Sudden death in explosives workers. Arch, environ. Health 7, 424 (1963).
Cartheuser, D.F., Komarek, J.: Effects of nitroglycerin on the circulation system, myocardial dynamics and left ventricular oxygen consumption in the anaesthetized beagledog. Basic Res. Cardiol. 74, 161 (1979).
Chatterjee, K.: Nitrates in acute and chronic heart failure. Amsterdam: Excerpta Medica 1979.
Chausseaud, L.F., Down, W.H., Grundy, R.K.: Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood of human subjects. Europ. J. clin. Pharmacol. 8, 157 (1975).
Chen, H.I., Chen, S.J., Cheng, C.F.: Direct and reflex effects of nitroglycerin on the blood volume distribution, evaluated by regional weighing in the cat. J. Pharm. Pharmacol. 31, 810 (1979).
Cheng, T.O.: Hypotension during coronary arteriography. Chest 60, 618 (1971).
Come, P. C., Pitt, B.: Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction. Circulation 54, 624 (1976).
Davidson, I.W.F., Miller, H.S. Jr., Dicarlo, F.J.: Pharmaco-dynamics and biotransformation of pentaerythritol tetranitrate in man. J. pharm. Sci. 60, 274 (1971 a).
Davidson, I.W.F., Rollins, F.O., Dicarlo, F.J., Miller, H.S. Jr.: The pharmacodynamics and biotransformation of pentaerythritol trinitrate in man. Clin. Pharmacol. Ther. 12, 972 (1971b).
Dicarlo, F.J., Crews, M.C., Haynes, L.J., Melgar, M.D., Gala, R. L.: The absorption and biotransformation of glyceryl trinitrate-l,3-14C by rats. Biochem. Pharmacol. 17, 2179 (1968).
Down, W.H., Chasseaud, L.F., Grundy, R.K.: Biotransformation of isosorbidedinitrate in humans. J. pharm. Sci. 63, 1147 (1974).
Elkayam, U., Kulick, D., Mcintosh, N., Roth, A., Hsueh, W., Rahimtoola, S.: Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. Circulation 76, 577 (1987).
Elliot, G.T., Quinn, S.L.: Nitroglycerin intravenous infusion. Drug. Intell. clin. Pharm. 16, 211 (1982).
Epstein, S. E., Redwood, D. R., Goldstein, R. E.: Angina pectoris: pathophysiology, evaluation, and treatment. Ann. intern. Med. 75, 263 (1971).
Feldman, R.L., Marx, J.D., Pepine, C.J., Conti, C.R.: Analysis of coronary responses to various doses of intracoronary nitroglycerin. Circulation 66, 321 (1982).
Ferrer, M.I., Bradley, S.E., Wheeler, H.O.: Some effects of nitroglycerin upon the splanchnic, pulmonary, and systemic circulations. Circulation 33, 357 (1966).
Fibuch, E.E., Cecil, W.T., Reed, W.A.: Methemoglobinemia associated with organic nitrate therapy. Anesth. Analg. 58, 521 (1979).
Flaherty, J.T.: Intravenous nitroglycerin. Johns Hopkins med. J. 151, 36 (1982).
Flaherty, J. T., Reid, P.R., Kelly, D.T., Taylor, D.R., Weis- Feldt, M.L., Pitt, B.: Intravenous nitroglycerin in acute myocardial infarction. Circulation 51, 132 (1975).
Flaherty, J. T., Becker, L.C., Bulkley, B.H., Weiss, J.L., Gerstenblith, G., Kallmann, C.H., Silverman, K.J., Wei, J. Y., Pitt, B., Weisfeldt, M. L.: A randomised prospective trial of intravenous nitroglycerin in patients with acute myocardial infarction. Circulation 68, 576 (1983).
Fung, H. L., Mcniff, E. F., Ruggirello, D., Darke, A., Tha- Dani, U., Parker, J. O.: Kinetics of isosorbide dinitrate and relationships to pharmacological effects. Brit. J. clin. Pharmacol. 11, 579 (1981 a).
Fung, H.L., Morrison, R.A., Kamiya, A.: Uptake and interaction of organic nitrates at blood vessel site. In: Mononitrat-Workshop Kronberg 1980 (M.Kaltenbach, W.D.Bussmann, A.Schrey, Hrsg.), S. 29. München: Dr. C.Wolf U. Sohn 1981b.
Fung, H.L., Sutton, S.C., Kamija, A.: Blood vessel uptake and metabolism of organic nitrates in the rat. Pharmacol, exp. Ther. 228, 334 (1984).
Gage, J. E., Hess, O. M., Murakami, T., Ritter, M., Grimm, J., Krayenbuehl, H.P.: Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 73, 865 (1986).
Glisson, S.N., El-Etr, A.A., Lim, R.: Prolongation of pancuronium-induced neuromuscular blockade by intravenous infusion of nitroglycerin. Anesthesiology 51, 47 (1979).
Gohlke-Bärwolf, C., Betz, P., Roskamm, H.: Wirkung und Wirkungsdauer eines transdermalen Nitrates (deponit 10) auf die Belastungsischämie. Eine Computer-Belastungs- EKG-Analyse. In: Depot-Nitrat (T.Meinertz, E.Jähnchen, A.Schrey, Hrsg.), S. 66. München: Verlag für angewandte Wissenschaften 1985.
Goldstein, R.E., Beiser, G.D., Stampfer, M., Epstein, S.E.: Impairment of autonomically mediated heart rate control in patients with cardiac dysfunction. Circulât. Res. 36, 571 (1975).
Habbab, M.A., Haft, J.J.: Heparin resistance induced by intravenous nitroglycerin. Arch. Intern. Med. 147, 857 (1987).
Hannemann, R.E., Erb, R.J., Stoltman, W.P., Bronson, E.C., Williams, E.J., Long, R.A., Hull, J.H., Starbuck, R. R.: Digital plethysmography for assessing erythrityl tetranitrate bioavailability. Clin. Pharmacol. Ther. 29, 35 (1981).
Heidemann, R., Menke, G., Letzel, H., Rietbrock, N.: Serumkonzentration von Glyceroltrinitrat (GTN) bei transdermaler Applikation von GTN-Pflastern unterschiedlicher Provenienz. Dtsch. med. Wochenschr. 110, 1568 (1985).
Herman, A.G., Bogaert, M.G.: Organic nitrates. Tolerance at the level of the vascular smooth muscle. Arch. int. Pharmacodyn. Ther. 192, 200 (1971).
Hill, N.S., Antmann, E.M., Green, L.H., Alpert, J.S.: Intravenous nitroglycerin - A review of pharmacology, indications, therapeutic effects and complications. Chest 9, 79 (1981).
Hogstedt, C, Andersson, K.: A cohort study on mortality among dynamite workers. J. occup. Med. 21, 553–556 (1979).
Horowitz, J.D., Antman, E.M., Lorrell, B.H., Barry, W.H., Smith, T.W.: Potentiation of cardiovascular effects of nitroglycerin by n-acetylcysteine. Circulation 66 (Suppl.II), 11–264 (1982).
Horwitz, L.D., Gorlin, R., Taylor, W.J., Kemp, H.G.: Effects of nitroglycerin on regional myocardial blood flow in coronary artery disease. J. clin. Invest. 50, 1578 (1971).
Ignarro, L.J., Lippton, H., Edwards, J.C., Baricos, W.H., Hyman, A.L., Kadowitz, P. J., Gruetter, C.A.: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol, exp. Ther. 218, 739 (1981).
Imhof, P.R., Vuillemin, T., Geradin, A., Racine, A.V.: Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS). Europ. J. clin. Pharmacol. 27, 7 (1984).
Jansen, W. C, Tauchert, M., Niehues, B., Hombach, V., Beh-Renbeck, D.W.: Koronardurchblutung und myocardialer Sauerstoffverbrauch vor und nach Einnahme von 0,8 mg Nitroglyzerin im Vergleich zu Atenolol. Med. Welt 31, 1313 (1980).
Jordan, R. A., Seth, L., Henry, D. A., Wilen, M. M., Francio- SA, J.A.: Dose requirements and hemodynamic effects of transdermal nitroglycerin compared to placebo in patients with congestive heart failure. Circulation 71, 900 (1984).
Jugdutt, B., Hutchins, G., Bulkley, B.H., Becker, L.: Reduction of infarct size by intravenous nitroglycerin infusion in conscious dogs. Circulation 57/58 (Suppl. 2 ), 11–98 (1978).
Kaltenbach, M., Schneider, W: Fortbestehen der antianginösen Wirksamkeit unter chronischer Nitrattherapie trotz Aufhebung hämodynamischer Teileffekte. Dtsch. med. Wochenschr. 111, 383 (1986).
Katsuki, S., Arnold, W., Mittal, C., Murad, F.: Stimulation of guanylate clyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. cyclic Nucleotide Protein Phosphor Res. 3, 23 (1977).
Kraupp, O.Th., Benke, P., Placheta, B., Stanek, G., Raber-Ger, G.: Die Wirkung einer einmaligen sowie chronischen Verabreichung von Isoket auf die Plasma-Renin-Aktivität von Hunden. In: Nitrate II: Wirkung auf Herz und Kreislauf (W.Rudolph, A.Schrey, Hrsg.), S. 17. München-Wien-Baltimore: Urban & Schwarzenberg 1980.
Kukovetz, W.R., Holzmann, S., Wurm, A., Pöch, G.: Evidence of cyclic GMP-mediated relaxant effects of nitrocompounds in coronary smooth muscle. Naunyn Schmiedebergs Arch. Pharmacol. 310, 129 (1979).
Lange, R.L., Reid, M.S., Tresch, D.D., Keelan, M.H., Bern- Hard, V.M., Coolidge, G.: Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. Circulation 46, 666 (1972).
Leier, C.V., Huss, R.N., Magorien, R.D., Unverferth, D.V.: Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation 67, 817 (1983).
Levin, R.I., Jaffe, E.A., Weksler, B.B., Tack-Goldman, K.: Nitroglycerin stimulates synthesis of prostacyclin by cultured human endothelial cells. J. clin. Invest. 67, 762 (1981).
Lichtlen, P., Halter, J., Gattiker, K.: The effect of isosorbiddinitrate on coronary blood flow, coronary resistance and left ventricular dynamics under exercise in patients with coronary artery disease. Basic Res. Cardiol. 69, 402 (1974).
Lund, R.P., Häggendahl, J., Johnsson, G.: Withdrawal symptoms in workers exposed to nitroglycerine. Brit. J. ind. Med. 25, 136 (1968).
Mannebach, H., Ohlmeier, H., Von Möllendorff, E., Gleichmann, U., Abshagen, U.: Steady-state Kinetik von Isosorbid-5-Mononitrat bei Patienten mit koronarer Herzkrankheit. Med. Welt 32, 517 (1981).
May, D.C., Popma, J.J., Black, W.H., Schaefer, S., Lee, H.R., Levine, B.D., Hillis, D.: In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries. N. Engl. J. Med. 317, 805 (1987).
Mcguiness, B.W., Harris, E.L.: “Monday head”, an interesting occupational disorder. Brit. med. J. 2, 745 (1961).
Mehta, J., Pepine, C.J.: Effect of sublingual nitroglycerin on regional flow in patients with and without coronary disease. Circulation 58, 803 (1978).
Mihalick, M.J., Rasmussen, S., Knoebel, S.B.: The effect of nitroglycerin on premature ventricular complexes in acute myocardial infarction. Amer. J. Cardiol. 33, 157 (1974).
Moir, T.W.: Subendocardial distribution of coronary blood flow and the effects of antianginal drugs. Circulât. Res. 30, 621 (1972).
Morrison, R.A., Fung, H.L., Höhmann, D., Meinertz, T., Jähnchen, E.: Isosorbide dinitrate: pharmacokinetics after intravenous administration. J. pharm. Sci. 71, 721 (1982).
Morrison, R.A., Wiegand, U.W., Jähnchen, E., Höhmann, M.D., Bechtold, H., Meinertz, T., Fung, H.L.: Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual, and percutaneous dosing in angina. Clin. Pharmacol. Ther. 33, 747 (1983 a).
Morrison, R.A., Wiegand, U.W., Jähnchen, E., Höhmann, D., Kasper, V., Meinertz, T., Fung, H.L.: Hepatic extraction of isosorbide dinitrate in cardiac patients. Clin. Pharmacol. Ther. 34, 724 (1983 b).
Needleman, P.: Tolerance to the vascular effects of glycerol trinitrate. J. Pharmacol, exp. Ther. 171, 98 (1970).
Needleman, P.: Biotransformation of organic nitrates. In: Handbook of experimental pharmacology, Vol.40: Organic nitrates (P.Needleman, E.M.Johnson, Hrsg.), S. 57. Berlin- Heidelberg-New York: Springer 1975.
Needleman, P., Johnson, E.M.: Mechanism of tolerance to organic nitrates. J. Pharmacol, exp. Ther. 184, 709 (1973).
Nemerovski, M., Shah, P.K.: Syndrome of severe bradycardia and hypotension following sublingual nitroglycerine administration. Cardiology 67, 180 (1981).
Noonan, P.K., Benet, L.Z.: Incomplete and delayed bioavailability of sublingual nitroglycerin. Amer. J. Cardiol. 55, 184 (1985).
Noonan, P.K., Benet, L.Z.: The bioavailability of oral nitroglycerin. J. pharm. Sci. 75, 241 (1986).
Ohlmeier, H., Mertens, H. M., Möller, M., Mannebach, H., Gleichmann, U.: Vereinfachte Langzeittherapie der koronaren Herzkrankheit mit 120 mg retardiertem Isosorbiddinitrat einmal täglich. Untersuchung zur Wirkdauer und Toleranzentwicklung. Z. Kardiol. 75 (Suppl.3), 50 (1986).
Oraretz, R., Lee, G., Baker, L.: Prominent dilation of stenotic coronary artery lesions following sublingual nitroglycerin by quantitative arteriography. Circulation 57/58 (Suppl. 2 ), 11–25 (1978).
Packer, M., Lee, W.H., Kessler, P.D, Gottlieb, S.S., Medina, N., Yushak, M.: Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N. Engl. J. Med. 317, 799 (1987).
Parker, J. O., Fung, H. L.: Transdermal nitroglycerin in angina pectoris. Amer. J. Cardiol 54, 471 (1984).
Parker, J.C., Dì Carlo, F.J., Davidson, I.W.F.: Comparative vasodilator effects of nitroglycerin, pentaerythritol trinitrate and biometabolites and other organic nitrates. Europ. J. Pharmacol. 31, 29 (1975).
Parker, J.O., Fung, H.L., Ruggirello, D., Stone, J.A.: Tolerance to isosorbide dinitrate: rate of development and reversal. Circulation 68, 1074 (1983).
Pascal, N.: Extracardiale Wirkungen der Nitrate. Herz/Kreislauf 17, 488 (1985).
Porchet, H., Bircher, J.: Noninvasive assessment of portal- systemic shunting: Evaluation of a method to investigate systemic availability of oral glycerol trinitrate by digital plethysmography. Gastroenterology 82, 629 (1982).
Platzer, R., Reutemann, G., Galeazzi, R.L.: Pharmacokinetic of intravenous isosorbidedinitrate. J. Pharmacokin. Biopharm. 10, 575–585 (1982).
Raijfer,. S. I., Demma, F.J., Goldberg, L.I.: Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin. Amer. J. Cardiol. 54, 120 (1984).
Raue, F., Ritz, E., Akpan, W., Endele, R., Neugebauer, G.: Kinetics of IS-5-MN and its glucuronide in patients with renal failure. In: Mononitrates (J.N.Cohn, R.Rittinghausen, Hrsg.), S. 78. Berlin-Heidelberg-New York-Tokyo: Springer 1985.
Reed, D.E., Akester, J.M., Prather, J.F., Tuckosh, J.R., Mccurdy, D.H., Yeh, C.: Blood and tissue levels of (14C) isosorbide dinitrate after oral and intravenous administration to rat. J. Pharmacol, exp. Ther. 202, 32 (1977).
Rees, J.R., Redding, V.J., Ashfield, R., Gibson, D., Gavey, C.J.: Myocardial blood flow measurement with 133xenon effect of glyceryl trinitrate. Brit. Heart. J. 28, 374 (1966).
Reichek, N., Priest, C., Zimrin, D., Chandler, T., Berger, N., Douglas, P., Sutton, M.S.J.: Antianginal effect of nitroglycerin over 24 hours: role of the method of administration. Circulation 70 (Suppl.II), 11–190 (1984).
Reichek, N., Priest, C., Zimrin, D., Chandler, T., Sutton, M.S.J.: Limited antianginal effects of nitroglycerin patches. Amer. J. Cardiol. 54, 1 (1984).
Reifart, N., Bräuner, M., Bussmann, W.-D.: Placebokon- trollierte Doppelblind-Studie zur Wirkdauer von transdermalem Depot-Nitrat. In: Depot-Nitrat (T. Meinertz, E.Jähnchen, A.Schrey, Hrsg.), S. 75. München: Verlag für angewandte Wissenschaften 1985.
Reiniger, G., Blasini, R., Brügmann, U., Rudolph, M.: Toleranzentwicklung hinsichtlich der antiischämischen Wirkung von Isosorbiddinitrat bei regelmäßiger Verabreichung. Herz 9, 146 (1984).
Reiniger, G., Kraus, F., Dirschinger, J., Blasini, R., Ru-Dolph, W.: Hochdosierte transdermale Nitroglycerintherapie: Wirkungsverlust innerhalb von 24 Stunden? Herz 10, 157 (1985).
Rezakovic, D. E., Lakatos, S., Majacic, M., Stalec, J., Pavi-Cic, L.: Doppelblinde plazebokontrollierte klinische Studie zur Wirksamkeit von Nitroglycerin-Pflaster bei stabiler Angina pectoris. In: Depot-Nitrat (T.Meinertz, E.Jähnchen, A.Schrey, Hrsg.), S. 82. München: Verlag für angewandte Wissenschaften 1985.
Rosseel, M.T., Bogaert, M.G.: GLC determination of nitroglycerin and isosorbide dinitrate in human plasma. J. pharm. Sci. 62, 754 (1973).
Rudolph, W., Blasini, R., Reiniger, G., Brügmann, U.: Tolerance development during isosorbide dinitrate treatment: Can it be circumvented? Z. Kardiol. 72 (Suppl.3), 195 (1983).
Schäfer, A. I., Alexander, R.W., Handin, R.I.: Inhibition of platelet function by organic nitrate vasodilators. Blood 55, 649 (1980).
Schneider, W., Stahl, M., Kaltenbach, M., Bussmann, W.D.: Dosis-Wirkungs-Beziehungen bei der Behandlung der Angina pectoris mit Isosorbiddinitrat. Dtsch. med. Wochenschr. 107, 771 (1982).
Schneider, W., Kett, U., Kaltenbach, M.: Antiischämische Wirkung einer 24stündigen kontinuierlichen Infusion mit Glyceroltrinitrat bei Patienten mit stabiler Angina pectoris. Dtsch. med. Wochenschr. 113, 543 (1988).
Schnellbacher, K., Samek, L., Blaschke, H.J., Roskamm, H.: Efficacy of isosorbide-5-mononitrate and diltiazem in patients with myocardial ischemia. II. International Symposium on Mononitrates, Berlin 1986.
Schrör, K., Grodzinska, L., Darius, H.: Stimulation of coronary vascular prostacyclin and inhibition of human platelet thromboxane A2 after low-dose nitroglycerin. Thromb. Res. 23, 59 (1981).
Schulz, V., Jansen, W., Pöhler, E., Tauchert, M.: Toleranz gegen Nitroglyzerin bei mehrtägiger intravenöser Zufuhr. Verh. dtsch. Ges. inn. Med. 88, 669 (1982).
Schwartz, A.M.: The cause, relief and prevention of headaches arising from contact with dynamite. New Engl. J. Med. 235, 541 (1946).
Sharpe, D.N., Coxon, R.: Nitroglycerin in a transdermal therapeutic system in chronic heart failure. J. cardiovasc. Pharmacol. 6, 76 (1984).
Silber, S.: Nitrattoleranz: Pro und Contra. Dtsch. med. Wochenschr. 109, 1124 (1984).
Silber, S., Krause, K., Garner, Ch., Theisen, K., Jahrmark-Ter, H.: Anti-ischemic effects of an 80 mg tablet of isosorbide dinitrate in sustained-release form before and after 2 weeks treatment with 80 mg once daily or twice daily. Z. Kardiol. 72 (Suppl.3), 211 (1983).
Spanggord, R.J., Keck, R.G.: Application of high-pressure liquid chromatography and thermal energy analyzer to analysis of trinitroglycerin and its metabolites in blood. J. pharm. Sci. 69, 444 (1980).
Spörl-Radun, S., Betzien, G., Kaufmann, B., Liede, V., Abshagen, U.: Effects and pharmacokinetics of isosorbide dinitrate in normal man. Europ. J. clin. Pharmacol. 18, 237 (1980).
Tauchert, M., Jansen, W., Ostersprey, A., Fuchs, M., Hom-Bach, V., Hilger, H.H.: Dose dependence of tolerance during treatment with mononitrates. Z. Kardiol. 72 (Suppl.3), 218 (1983).
Tauchert, M., Jansen, W., Ostersprey, A.: Nitrate, Nitratdosen und Toleranz. In: Mononitrate 4 (U.Borchard, W.Raf- Flenbeul, A.Schrey, Hrsg.). S. 45. München: Dr. C.Wolf u. Sohn 1985.
Taylor, T., Chasseaud, L.F., Major, R., Doyle, E.: Isosorbide-5-mononitrate pharmacokinetics in humans. Biopharm. Drug. Dispos. 2, 255 (1981).
Taylor, T., Chasseaud, L. F., Doyle, E., Bonn, R., Darragh, A., Lambe, R. F.: Isosorbide dinitrate pharmacokinetics. Arzneim.-Forsch. (Drug Res.) 32, 1329 (1982).
Thadani, U., Kellerman, D.: Interaction of indomethacin on hemodynamics and exercise tolerance in patients with angina pectoris. Z. Kardiol. 72 (Suppl.3), 35 (1983).
Thadani, U., Fung, H.L., Darke, A.C., Parker, J.O.: Oral isosorbide dinitrate in angina pectoris. Comparison of duration of action and dose-response relation during acute and sustained therapy. Amer. J. Cardiol. 49, 411 (1982).
Thompson, R.: Clinical use of transdermal delivery devices with nitroglycerin (abstr.). Circulation 67 (Suppl.3), 111–407 (1983).
Trompler, A.T., Sold, G., Kaiser, H., Wiegand, V., Kreuzer, H.: Development of tolerance during nitrate therapy: Dissociation of arterial and venous effects. Z. Kardiol 72 (Suppl.3), 191 (1983).
Vatner, S. F., Heyndricks, G. R.: Mechanism of action of nitroglycerin: coronary, cardiac and systemic effects. In: Handbook of experimental pharmacology, Vol.40: Organic nitrates (P. Neddleman, Hrsg.), S. 131. Berlin-Heidelberg- New York: Springer 1975.
Vatner, S. F., Pagani, M., Rutherford, J. D., Millard, R. W., Manders, W.T.: Effects of nitroglycerin on cardiac function and regional blood flow distribution in conscious dogs. Amer. J. Physiol. 234, 244 (1978).
Wagner, F., Siefert, F., Trenk, D., Jähnchen, E.: Beziehung zwischen Plasmakonzentration und hämodynamischer Toleranz gegenüber Isosorbid-5-Mononitrat (IS-5-MN). Z. Kardiol. 75 (Suppl.I), 25 (1986).
Wille, H. H., Sauer, G., Tebbe, U., Neuhaus, K. L., Kreuzer, H.: Nitroglycerin and afterload: effects of aortic compliance and capacity of the Windkessel. Europ. Heart J. 1, 445 (1980).
Winbury, M.M., Howe, B.B., Hefner, M.A.: Effect of nitrates and other coronary dilators on large and small coronary vessels: a hypothesis for the mechanism of action of nitrates. J. Pharmacol, exp. Ther. 168, 70 (1969).
Windorfer, A.: Nitroglycerin blood level after buccal and oral application of synchron nitroglycerin. In: Controlled release nitroglycerin in buccal and oral form, advances in pharmacotherapy (W.D.Bussmann et al., Hrsg.), S. 44. Basel: Karger 1982.
Wizemann, A.: Zweijährige Erfahrungen mit peroraler Nitrattherapie des Glaukoms. Fortschr. Ophtalmol. 79, 149 (1982).
Yacobi, A., Amann, A.H., Baaske, D.M.: Pharmaceutical considerations of nitroglycerin. Drug Intell. clin. Pharm. 17, 255 (1983).
Zimrin, D., Reichek, N., Bogin, K.T., Aurigemma, G., Douglas, P., Berko, B., Fung, H.L.: Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation 77, 1376 (1988).
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Jähnchen, E. (1989). Organische Nitrate. In: Herzkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97060-3_34
Download citation
DOI: https://doi.org/10.1007/978-3-642-97060-3_34
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-97061-0
Online ISBN: 978-3-642-97060-3
eBook Packages: Springer Book Archive